High Frequency Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Post-traumatic Stress Disorder (PTSD)

Inclusion Criteria: * Signed Patient Information and Consent. * Patients with primary Post-Traumatic Stress Disorder (as diagnosed by MINI) and DSM IV TR. * Patients with CAPS score of at least 40. * Males or females between 18-65 years of age. * Patients not taking PTSD pharmacotherapy for at least last 2 weeks prior to commencing in the study or if they are taking PTSD pharmacotherapy it must be stable for at least 6 weeks prior to the start and not be changed during the 6 weeks of the study treatment phase. * Individual or group supportive psychotherapy may continue during the study but will not be allowed to start new psychotherapy during the 6 weeks of the study treatment phase. Exclusion Criteria: * Current primary Axis I disorder including Schizophrenia, Bipolar Disorder type I, Major Depressive Disorder. * Other primary Axis I disorders which, in the opinion of the investigator, may affect the outcome of this study. * Patients with HDRS score ≥ 18. * A metallic implant in cranium (except the mouth). * Patients with severe or unstable medical conditions, which in the opinion of the investigator would interfere with their progress or safety. * ECT treatment within the last three months. * Patients with a history of epilepsy. * Patients with neurological disorder leading to increased intracranial pressure. * Patients with severe cardiac disorder or intracardiac lines and pacemakers. * Patients with current suicide risk ≥ 6 points by MINI.